Skip to main content
SpringerLink
Log in

Atezolizumab/bevacizumab

Immune-mediated myositis

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Ono S, et al. A case of atezolizumab- and bevacizumab-induced myositis showing high intensity in the pterygoid muscles, soft palate, and tongue on STIR-MRI. [Japanese] Rinsho Shinkeigaku 63 : 582-587, No. 9, Jan 2023. Available from: URL: https://dx.doi.org/10.5692/clinicalneurol.cn-001876 [Japanese; summarised from an English abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Atezolizumab/bevacizumab. Reactions Weekly 1989, 36 (2024). https://doi.org/10.1007/s40278-024-52182-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-52182-x

Search

Navigation